Literature DB >> 26383525

Comment on "High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma".

Luca Antonioli1, Antonello di Paolo2, Matteo Fornai2, Romano Danesi2, Corrado Blandizzi2.   

Abstract

Entities:  

Keywords:  Adenosine; CD39; CD73; Cancer; Tumor microenvironment

Mesh：

Substances：

Year:  2015        PMID： 26383525     DOI： 10.1007/s13277-015-4030-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  9 in total

1.  Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.

Authors:  Beat M Künzli; Maria-Isabell Bernlochner; Stephan Rath; Samuel Käser; Eva Csizmadia; Keiichi Enjyoji; Peter Cowan; Anthony d'Apice; Karen Dwyer; Robert Rosenberg; Aurel Perren; Helmut Friess; Christoph A Maurer; Simon C Robson
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

Review 2.  Rectal and colon cancer: Not just a different anatomic site.

Authors:  K Tamas; A M E Walenkamp; E G E de Vries; M A T M van Vugt; R G Beets-Tan; B van Etten; D J A de Groot; G A P Hospers
Journal:  Cancer Treat Rev       Date:  2015-06-28       Impact factor: 12.111

3.  Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.

Authors:  Beat M Künzli; Pascal O Berberat; Thomas Giese; Eva Csizmadia; Elzbieta Kaczmarek; Colin Baker; Irfan Halaceli; Markus W Büchler; Helmut Friess; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-17       Impact factor: 4.052

4.  High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma.

Authors:  Bin Zhang; Bo Cheng; Feng-Sheng Li; Jian-Hua Ding; Ying-Ying Feng; Guang-Zuan Zhuo; Hua-Feng Wei; Ke Zhao
Journal:  Tumour Biol       Date:  2015-06-27

5.  Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.

Authors:  Paul A Beavis; Nicole Milenkovski; Melissa A Henderson; Liza B John; Bertrand Allard; Sherene Loi; Michael H Kershaw; John Stagg; Phillip K Darcy
Journal:  Cancer Immunol Res       Date:  2015-02-11       Impact factor: 11.151

Review 6.  CD39 and CD73 in immunity and inflammation.

Authors:  Luca Antonioli; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  Trends Mol Med       Date:  2013-04-17       Impact factor: 11.951

Review 7.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

Review 8.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

Review 9.  The roles of CD73 in cancer.

Authors:  Zhao-wei Gao; Ke Dong; Hui-zhong Zhang
Journal:  Biomed Res Int       Date:  2014-07-14       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.